/ 2 items

#NVCR↓

NVCR/ 02/25/2026 · 9:12 AM

NovoCure’s Medicare Scare Lasts Just 22 Days — Billing Fully Restored, No Revenue Hit

NovoCure’s (NVCR) Medicare billing privileges were briefly revoked due to a paperwork glitch but fully restored retroactively on Feb 24, 2026. Patients continued care with zero expected revenue impact.

Featured/ NVCR/ 02/12/2026 · 6:07 AM

FDA Approves Novocure's Optune Pax: A New Hope for Pancreatic Cancer Patients

Novocure's Optune Pax wearable device wins FDA approval for locally advanced pancreatic cancer with gemcitabine + nab-paclitaxel. Phase 3 trial shows improved survival and delayed pain progression.